Success Stories: Vietnamese Postdoctoral Research Fellow Secures EB1A Approval for Cancer Biology Contributions

Client’s Testimonial:

“I am highly satisfied with the professional guidance and assistance of the wegreened I-140 team to during preparation of the I-140 petion which resulted in the EB1A approval in such a short period of time. They have perfectly outlined and emphasized my research in a fascinating way. I am happy to recommend Wegreened service to anyone in need of a professional service regarding Employment-based petition. Wonderful Job! Thank you!”

On September 4^th, 2025, we received another EB1A (Alien of Extraordinary Ability) approval for a Postdoctoral Research Fellow in the field of Bioinformatics (Approval Notice).

General Field: Bioinformatics

Position at the Time of Case Filing: Postdoctoral Research Fellow

Country of Origin: Vietnam

State of Residence at the Time of Filing: Texas

Approval Notice Date: September 4^th, 2025

Processing Time: 16 days (Premium Processing Requested)

Case Summary:

We are pleased to share the EB1A approval of a postdoctoral research fellow from Vietnam. At the time of filing, he was conducting research in the United States on bioinformatics and cancer biology, advancing computational oncology and precision medicine. His extensive publication record, high citation impact, and sustained service as a reviewer and editor established him as a persuasive candidate for EB1A approval.

Extraordinary Research with Global Impact

The client’s contributions span identifying cancer-specific expression patterns of calcium channels, discovering biomarkers and therapeutic targets in breast cancer, and applying deep learning and multimodal AI approaches to improve cancer prognosis. His findings have been adopted in studies of kidney cancer genetics, immune evasion in gastric cancer, and breast cancer histology, demonstrating a wide-ranging impact on oncology and personalized medicine.

Well Positioned to Advance the Field

The client holds a Ph.D. in bioinformatics and has authored 48 peer-reviewed journal articles, 15 of them as first or co-first author, along with 2 conference abstracts. His work has been cited over 1,800 times by independent researchers, with at least 10 papers ranked among the most highly cited in molecular biology and genetics for their publication years. His citation record places him among the top 1 percent of computational science authors and the top 2 percent of bioinformatics researchers worldwide.

Beyond publications, he has completed more than 20 peer reviews for respected journals such as Computers in Biology and Medicine and npj Precision Oncology. He also serves on editorial boards for PLOS ONE, Discover Oncology, Frontiers in Bioinformatics, and Frontiers in Oncology, underscoring his recognition as a trusted authority in the field.

Recognition from Field Experts

Independent recommenders confirmed the originality and importance of his work.
One expert noted:

“Above all, [client]’s contributions are essential to the United States’ efforts to advance personalized cancer treatment, improve diagnostic accuracy, and develop next-generation therapeutic strategies that address the growing burden of cancer-related public health challenges.”

This endorsement highlights how his research bridges scientific innovation with pressing clinical needs.

EB1A Approval and Outlook

The I-140 EB1A petition was filed on August 19, 2025, upgraded to premium processing, and approved on September 4, 2025. USCIS recognized his publication record, international citation impact, peer review and editorial service, and his highly regarded research as sufficient to satisfy the EB1A standard.

With NAILG’s guidance, the client secured EB1A approval and is now positioned to continue his critical research in bioinformatics and cancer biology. His ongoing research promises to advance precision oncology, improve patient outcomes, and reinforce U.S. leadership in biomedical innovation.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.